Parcion Private Wealth LLC Bristol Myers Squibb CO Transaction History

Parcion Private Wealth LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$47.98 - $54.4 $8,588 - $9,737	-179 Reduced 3.13%	5,534 $300,000
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $8,805 - $9,987	134 Added 2.4%	5,713 $395,000
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $18,881 - $20,794	260 Added 4.89%	5,579 $409,000
Q1 2022 May 06, 2022	SELL	$61.48 - $73.72 $16,046 - $19,240	-261 Reduced 4.68%	5,319 $408,000
Q4 2021 Feb 08, 2022	BUY	$53.63 - $62.52 $53 - $62	1 Added 0.02%	5,580 $362,000
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $15,798 - $18,505	267 Added 5.03%	5,579 $326,000
Q1 2021 Apr 08, 2021	SELL	$59.34 - $66.74 $32,637 - $36,707	-550 Reduced 9.38%	5,312 $335,000
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $115,480 - $130,860	2,000 Added 51.79%	5,862 $364,000
Q3 2020 Oct 20, 2020	SELL	$57.43 - $63.64 $74,659 - $82,732	-1,300 Reduced 25.18%	3,862 $227,000
Q1 2020 Apr 29, 2020	SELL	$46.4 - $67.43 $17,492 - $25,421	-377 Reduced 6.81%	5,162 $288,000
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $272,574 - $355,548	5,539 New	5,539 $356,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Parcion Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Parcion Private Wealth LLC with notifications on news.